Immune cytotoxicity assay

What is a immune cytotoxicity assay?

The immune cytotoxicity assay is a laboratory method used to measure the ability of specialized immune cells (effector cells) or cytotoxic compounds to induce cell damage or cell death in target cells. These assays provide a quantitative assessment of cellular toxicity or cytolytic activity, making them essential tools in drug discovery, immunology, toxicology and cancer research.

OUR IMMUNE CYTOTOXICITY ASSAY SERVICES

What is the purpose of cytotoxicity testing?

Immune cytotoxicity assays play a key role in drug discovery, preclinical development, and safety evaluation.

Cytotoxicity assays are essential for:

Evaluating immune effector functions, such as natural killer (NK) cell or cytotoxic T lymphocyte (CTL) activity to eliminate target cells
Assessing the toxic effects of drug candidates, chemicals, or biologics on cultured cells
Enhanced antigen presentation via major histocompatibility complexes (MHC)
Screening therapeutic candidates for safety or anti-cancer activity

How immune cytotoxicity assays work

In a typical immune cytotoxicity assay, target cells—often tumor cells, infected cells, or other susceptible cell types—are labeled or otherwise marked to allow detection of cell viability. Effector cells, such as NK cells or antigen-specific CTLs, are then co-cultured with these target immune effector cells at defined ratios.

Interactions between effector and target cells can result in target cell death via apoptosis, necrosis, or other cytolytic mechanisms. Cell death or loss of viability is then quantified using a variety of detection methods, providing a measure of immune cell potency, specificity, and cytolytic activity.

Methods for measuring cytotoxicity

Cytotoxicity can be measured using a variety of methods each based on a different biological readout of cell damage or loss of viability. One of the main events that occur after cell death is the loss of membrane integrity, which allows chemicals or proteins to freely enter or exit the cell.

Types of cytotoxicity assays:

Release cytotoxicity assays
Release assays (also known as membrane integrity assays) detect intracellular enzymes (e.g., lactate dehydrogenase, LDH) released upon cell lysis into the culture medium. Quantifying LDH activity in the culture supernatant provides a direct measure of cell lysis and cytotoxicity.
Fluorescent and luminescent cytotoxicity assays
Modern cytotoxicity assays often use fluorescent dyes or luminescent substrates to detect dead cells or changes in cellular metabolism. Fluorescent DNA-binding dyes bind and stain nucleic acids in cells with compromised membranes (permeable dead cells), while luminescent assays frequently measure intracellular ATP levels, which correlate viable cell numbers.

Other methods involve flow cytometry–based detection of dead cells, or real-time imaging to monitor target cell survival over time.

The results of immune cytotoxicity assays provide critical information on the potency and specificity of immune responses, the safety profile of drug candidates, and the functional activity of cytolytic immune cells. This assay is widely applied in immunology, oncology, infectious disease research, and preclinical evaluation of immunotherapies.

How to choose an immune cytotoxicity assay?

Selecting the right assay can be challenging, as the optimal approach depends on your research goals, cell types, and experimental conditions.

Essential factors include:

Cell type
NK cells, T cells (autologous effector cells or HLA restricted)
Key readouts
Cell death
Mechanism of cell death
Time course
Selection of early (hours) versus late (24–72h) cytotoxic responses, including single or multiple time points
Throughput and sensitivity
Adaptation to low- or high-throughput screening, and required sensitivity
Detection method
Choice of fluorescence-, luminescence-, or flow cytometry-based readouts; potential for multiplexing multiple endpoints

Additional factors such as assay sensitivity, throughput, and reproducibility should also be considered when designing your study.

Key immune cytotoxicity assay considerations

Additional parameters are critical for robust and reproducible results.

Effector-to-target ratio (E:T ratio)
A key variable in immune cell–mediated cytotoxicity assays that directly impacts response magnitude
Donor variability
Use of primary human cells introduces biological variability; careful donor selection improves translatability
Controls
Appropriate positive and negative controls are essential for assay validation and data interpretation
Reproducibility and cost
Balancing robustness, scalability, and cost-efficiency for your specific project needs

Our immune cytotoxicity assay service

Cytotoxicity assays are frequently used in the preclinical evaluation of therapeutic candidates, where reliable quantification of cell death and cell health is essential.

We provide specialized laboratories and immune cell cytotoxicity testing services and can guide you through every step of the process.

Our portfolio includes a variety of methods to measure cytotoxicity such as lactate dehydrogenase (LDH) release, nuclear staining by DRAQ7 or expression of Annexin V on the cell surface.

These assays deliver critical information on the potency and specificity of immune responses, the safety profile of drug candidates, and the functional activity of cytolytic immune cells.

Direct access to human blood samples

As a sister company of BIOMEX, we have direct access to high-quality human biospecimens and a well-established global network of collection centers. This unique setup enables us to:

Source fresh peripheral blood samples and isolate relevant effector cell populations (e.g., T cells, NK cells) with defined donor characteristics (HLA typing)
Minimize assay variability through standardized collection, processing, and handling protocols tailored for cytotoxicity readouts
Access diverse donor cohorts to generate more predictive and translatable cytotoxicity and immune response data
Ensure rapid sample availability, enabling fast turnaround times and high reproducibility in time-sensitive cytotoxicity assays

This integrated approach strengthens the physiological relevance and consistency of your cytotoxicity studies, supporting more confident decision-making in preclinical development.

What we support you with

We work closely with you to design and execute bioassays tailored to your specific research needs:

Selection the right assay type for your research question
Experimental design for optimal sensitivity and reproducibility
Set up of high-throughput or multiplexed assays, if required
Data analysis and interpretation with expert guidance

Contact us